Want to see NVST full AI Analyst Report?
NVST Stock Chart & Stats
$27.84
-$0.72(-3.69%)
At close: 4:00 PM EST
$27.84
-$0.72(-3.69%)
Day’s Range― - ―
52-Week Range$18.77 - $30.42
Previous CloseN/A
Volume757.64K
Average Volume (3M)2.71M
Market Cap
$4.22B
Enterprise Value$4.55B
Total Cash (Recent Filing)$1.08B
Total Debt (Recent Filing)$1.59B
Price to Earnings (P/E)61.7
Beta1.02
Next Earnings
Aug 05, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.42
Shares Outstanding162,727,920
10 Day Avg. Volume2,659,666
30 Day Avg. Volume2,711,539
Financial Highlights & Ratios
PEG Ratio-0.74
Price to Book (P/B)1.17
Price to Sales (P/S)1.34
P/FCF Ratio15.83
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue1.62
Enterprise Value/Gross Profit2.94
Enterprise Value/Ebitda13.13
Forecast
1Y Price Target
$29.00Price Target Upside4.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)1.43
Revenue Forecast (FY)$2.86B
Bulls Say, Bears Say
Bulls Say
High Gross Margins And Strong Free Cash FlowEnvista’s durable gross margin base (~55%) and healthy TTM free cash flow ($220.2M) indicate a structurally profitable product mix (consumables plus equipment). Strong cash generation supports reinvestment, tuck‑in M&A and capital returns, reducing reliance on volatile earnings to fund strategy.
Product Innovation Driving Volume And Share GainsNew-product momentum (Nobel S Series, Spark, DEXIS enhancements) is producing measurable volume and conversion from competitors, underpinning durable top‑line growth. Technology-led adoption supports recurring consumable sales and pricing power across implant, ortho and diagnostics segments.
Conservative Leverage And Active Capital AllocationNet debt below 1x and a sizable equity base give Envista financial flexibility. Management’s mix of repurchases and accretive tuck‑in M&A demonstrates disciplined capital allocation, enabling sustained investment in growth while returning cash to shareholders when appropriate.
Bears Say
Thin Net Margins And Low ROEDespite margin expansion at the gross level, net profitability and returns on equity remain low and volatile. Thin net margins and uneven earnings reduce the company’s ability to consistently fund growth from internal returns and increase sensitivity to cost shocks or cyclical demand.
China Implants VBP And Channel Destocking RiskPending volume‑based procurement (VBP) and channel inventory adjustments in China create structural uncertainty for implants revenue and pricing. Procurement reforms can compress channels and margins, producing sustained headwinds in a high‑growth but policy‑sensitive market.
Ongoing Tariff And CapEx Pressure On Cash FlowNear‑term negative FCF from elevated CapEx and recurring tariff/trade costs (management cited ~$11M tariffs) can strain cash conversion if sustained. Continued investment and higher trade costs reduce short‑term liquidity and could limit optionality if profit recovery falters.
Envista Holdings News
NVST FAQ
What was Envista Holdings’s price range in the past 12 months?
Envista Holdings lowest stock price was $18.77 and its highest was $30.42 in the past 12 months.
What is Envista Holdings’s market cap?
Envista Holdings’s market cap is $4.22B.
When is Envista Holdings’s upcoming earnings report date?
Envista Holdings’s upcoming earnings report date is Aug 05, 2026 which is in 22 days.
How were Envista Holdings’s earnings last quarter?
Envista Holdings released its earnings results on May 06, 2026. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.312 by $0.048.
Is Envista Holdings overvalued?
According to Wall Street analysts Envista Holdings’s price is currently Undervalued.
Does Envista Holdings pay dividends?
Envista Holdings does not currently pay dividends.
What is Envista Holdings’s EPS estimate?
Envista Holdings’s EPS estimate is 0.34.
How many shares outstanding does Envista Holdings have?
Envista Holdings has 162,727,920 shares outstanding.
What happened to Envista Holdings’s price movement after its last earnings report?
Envista Holdings reported an EPS of $0.36 in its last earnings report, beating expectations of $0.312. Following the earnings report the stock price went down -10.27%.
Which hedge fund is a major shareholder of Envista Holdings?
Currently, no hedge funds are holding shares in NVST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Envista Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$29.00 (4.17% Upside)
$29.00 (4.17% Upside)
Blogger Sentiment
Bullish
NVST Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 2.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 1.2%
Last 30 Days ▲ 1.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
25.04%
12-Months-Change
Fundamentals
Return on Equity
2.18%
Trailing 12-Months
Asset Growth
2.04%
Trailing 12-Months
Company Description
Envista Holdings
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
NVST Revenue Breakdown
63.99% Specialty Products & Technologies
36.01% Equipment & Consumables
NVST Stock 12 Month Forecast
Average Price Target
$29.00
▲(4.17% Upside)
Technical Analysis
DENTSPLY SIRONA
―
Disc Medicine
―
Clover Health Investments
―
AbCellera Biologics
―
Bausch + Lomb Corporation
―
Ownership Overview
0.74% Insiders
37.62% Mutual Funds
0.16% Other Institutional Investors
36.59% Public Companies and
Individual Investors